MedTrace Logo

Sympathetic Activity and Cardiometabolic Complications

NCT04495231 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1380

Last updated 2020-07-31

No results posted yet for this study

Summary

Recent studies on catecholamine physiology have shown a direct correlation with arterial hypertension, overcoming the exclusive role in the diagnosis and follow-up of chromaffin tumors.

Nevertheless, in literature, few studies explore and reveal the utility of testing metanephrines for the evaluation of sympathetic activity and its associated cardiometabolic complications in patients with essential hypertension.

Conditions

  • Catecholamine; Overproduction
  • Catecholamine; Secretion
  • Metabolic Syndrome
  • Hypertensive Heart Disease
  • Hypertensive Kidney Disease
  • Diabetes Mellitus, Type 2
  • Hypertension,Essential

Sponsors & Collaborators

  • University of Turin, Italy

    lead OTHER

Principal Investigators

  • Mauro Maccario, MD · Endocrinology, Diabetology and Metabolism; University of Turin

  • Ezio Ghigo, MD · Endocrinology, Diabetology and Metabolism; University of Turin

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-01
Primary Completion
2015-07-01
Completion
2020-07-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04495231 on ClinicalTrials.gov